key: cord-0862666-6r2g8hbs
authors: Otunuga, Olusegun M.
title: Estimation of epidemiological parameters for COVID-19 cases using a stochastic SEIRS epidemic model with vital dynamics
date: 2021-08-11
journal: Results Phys
DOI: 10.1016/j.rinp.2021.104664
sha: 9a2d7b6b1e93ef9e68ee3ccca5dc8d6733d0b4ef
doc_id: 862666
cord_uid: 6r2g8hbs

We estimate and analyze the time-dependent parameters: transmission rate, symptomatic recovery rate, immunity rate, infection noise intensities, and the effective reproduction number for the United States COVID-19 cases for the period 01/22/2020-02/25/2021 using an innovative generalized method of moments estimation scheme. We assume the disease-dynamics is described by a stochastic susceptible-exposed-infected-recovered-susceptible (SEIRS) epidemic model, where the infected class is divided into the asymptomatic infected, and symptomatic infectious classes. Stochasticity appears in the model due to fluctuations in the disease’s transmission and recovery rates. The disease eradication threshold is derived from the reproduction number. The estimated parameters are used to model the disease outbreak’s possible trajectories. Our analysis reveals that current interventions are having positive effects on the transmission and recovery rates. The analysis is demonstrated using the daily United States COVID-19 infection and recovered cases for the period: 01/22/2020-02/25/2021.

Several mathematical models [8, 9, 45, 40, 17, 28, 27, 26, 22, 37] have been developed to study the transmission of the COVID-19 virus caused by the virus species "severe acute respiratory syndrome-related coronavirus", named SARS-CoV-2. The virus has caused over thirty million active cases and over 600 million deaths in the United States as of July, 2021. The airborne transmission occurs by inhaling droplets loaded with SARS-CoV-2 particles that are expelled by infectious people. According to the United States Centers for Disease Control and Prevention (CDC) 1 , the best way to prevent the disease is to avoid being exposed to the virus. There are two other novel coronaviruses, namely, "severe acute respiratory syndrome coronavirus" (SARS-CoV) and the "Middle East respiratory syndrome coronavirus" (MERS-CoV) that emerged as major global health threats since 2002, according to Wu et al. [45] . Knowledge about the transmission of the infectious disease can help control the spread of the disease. Several vaccinations have been developed to eradicate or reduce the transmission of the virus. On December 11, 2020, the United States Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) for the Pfizer-BioNTech Covid-19 vaccine to be used in the United States. The first dose of the vaccine was administered on December 14, 2020 . This is the first vaccine administered in the United States. Seven days later, the FDA approved an EUA for the Moderna COVID-19 vaccine in the United States. The third vaccine, The Johnson and Johnson (J&J) vaccine, was first issued in the United State on February 27, 2021. As of July 24, 2021, only 68.7% of adults in the United States have taken at least one of the three vaccination. Data reported by CDC 2 shows that the daily count of total doses of the vaccines administered increases in trend from December 13, 2020 to February, 14, 2021, with a slight decline from

We use a deterministic susceptible, infected but not infectious (exposed), asymptomatic infected, symptomatic infectious, and recovered model, with compartments denoted by S, E, I 1 , I 2 , and R, respectively, to describe the transmission of the Covid-19 disease in the United States. By exposed, we mean someone who got infected (but not infectious) by being in close contact with someone who has Covid-19. A full list of what counts as close contact is provided by the Centers for Disease Control and Prevention (CDC) 4 . The S EIRS model with vital rates governing the transmission of the virus is described by the following deterministic system of nonlinear differential equations:

S (ηI 1 + I 2 ) N − µS + γ(t)R dt, S(t 0 ) = S 0 , dE = β(t) S (ηI 1 + I 2 ) N − (α + µ)E dt, E(t 0 ) = E 0 , dI 1 = ((1 − p)αE − (r I + µ) I 1 ) dt, I 1 (t 0 ) = I 10 , (2.1) dI 2 = (αpE − (ν(t) + µ)I 2 ) dt, I 2 (t 0 ) = I 20 , dR = (ν(t)I 2 + r I I 1 − (γ(t) + µ)R) dt,

where S 0 > 0, E 0 > 0, I 10 > 0, I 20 > 0, R 0 > 0, and S(t), E(t), I 1 (t), I 2 (t), R(t) are the population of susceptible, infected but not infectious (exposed), asymptomatic, symptomatic infectious, and temporarily immune (temporarily recovered) individuals, respectively, at time t ≥ t 0 . Here, β(t) is the time-dependent transmission or contact rate in response to public health interventions. We assume every individual is in one of these compartments at t 0 with N = S 0 + E 0 + I 10 + I 20 + R 0 , where N is the population size of the United States, so that S + E + I 1 + I 2 + R = N for all time t. The transmission rate, symptomatic recovery rate, and temporary immune rate β(t), ν(t), and γ(t), respectively, are assumed to be a positive, bounded, and continuous function of time t. The latency and death rates α and µ, respectively, are each positive constants, with α being the transition rate from the exposed to infectious class. The parameter p ≥ 0 is the fraction of infection cases that are symptomatic, and r I is the asymptomatic recovery rate. The parameter η accounts for the infectiousness of asymptomatic individuals relative to symptomatic. According to the CDC 5 , a parameter value of η = 50% means an asymptomatic individual is half as infectious as a symptomatic individual, whereas a parameter value of 100% means that an asymptomatic individual is just as likely to transmit infection as a symptomatic individual. We assume that the transmission, symptomatic recovery, and temporary immune rates β(t), ν(t), and γ(t), respectively, of the Covid-19 virus are functions of time and are unknown. We also assume the asymptomatic recovery rate r I is unknown. By studying the trajectories of the number of Covid-19 infection cases in the United States, we noticed, from the spikes in the trajectory of the number of cases, that it is influenced by some external noise. These noises can be caused by many factors such as the rates at which Covid-19 testing is done, vaccination rates, variability in the number of contacts between infected and susceptible individuals, mask use per capital, social behavior, public health intervention, and so on. Since no much information is known about the temporary immune rates γ(t) of the virus, we only assume in this study that the transmission and recovery rates are influenced by Gaussian white noise processes causing the rates to fluctuate around the function β(t) and ν(t), respectively. As mentioned above, external fluctuations may be caused by many factors such as public health interventions and variability in the number of contacts between infected and susceptible individuals, and such random variations can be modeled by a white noise. Thus we assume where ζ i (t), i = 1, 2 are independent Gaussian white noise term with mean 0 such that ζ i (t)dt = dW i (t), σ i (t), i = 1, 2, are the noise intensities for the transmission and symptomatic recovery rates, respectively, W i (t), i = 1, 2, are independent standard Weiner process defined on a complete filtered probability space (Ω, F , (F t ) t≥0 , P), (F t 0 ) is measurable and (F t ) t≥0 is right continuous. We also assume that (S 0 , E 0 , I 10 , I 20 , R 0 ) is F t 0 -measurable and independent of W i (t) − W i (t 0 ), i = 1, 2. By substituting (2.2) into (2.1), the dynamics describing the system is interpreted using Stratonovich S EIRS equation with vital rates and stochasticity as

where • is the Stratonovich integral symbol. We direct readers interested in a review of stochastic modeling with systems of differential equations, and the interpretation of stochastic dynamic systems as a Stratonovich system to the work of Kloeden [14] , Ladde [15] , and Méndez et al. [24] . Model (2.3) performs better than existing SEIRS deterministic model in the sense that it is able to capture fluctuations in the number of susceptible, exposed, infections, and recovered cases. Another advantage the model has over other existing model is the fact that it captures the trajectories of the susceptible, exposed, infected, and recovered population well because the transmission, recovery, and the immunity rates are extracted for each given time rather than as a constant over time. We convert the population sizes S, E, I 1 , I 2 , and R to percentages using the transformation

respectively. Using these transformations, equation (2.3) reduces to

We convert (2.4) into Itô stochastic differential equation as

We assume that all model parameter values are known, except β(t), ν(t), γ(t), r I , and σ i (t), i = 1, 2. Also we assume that the infectious I 1 (t), I 2 (t) and recovered R(t) population data are known and noise-free at discrete time points t j and can be modeled with the S EIRS model (2.5) . The goal of the work done here is to identify the time-dependent parameters β(t), ν(t), γ(t) and σ i (t), i = 1, 2, effective and basic reproduction number R e (t) and R 0 , respectively, specifically at each time t j for the Covid-19 infection when I 1 , I 2 , and R are known. To do this, we need to first estimate E(t) and S (t) at each time t using the local lagged adapted generalized method of moments (LLGMM) parameter estimation scheme described in the patent work of Ladde and Otunuga [29] . The estimated parameters are used to model the disease outbreak's possible trajectories.

In this section, we describe, assuming the infected I 1 (t), I 2 (t), and recovered R(t) population data are known, how the exposed E(t) and susceptible S (t) population, together with the transmission β(t), recovery ν(t), and temporary immune γ(t) rates are estimated using the LLGMM scheme. These estimates are used to calculate the basic and effective reproduction numbers of Covid-19 cases for the United States for the time period: March 1, 2020 to February 25, 2021. The LLGMM method described in the patent is composed of the following components: (1) development of a stochastic mathematical model of the continuous time dynamic process, (2) construction of an equivalent time series model, (3) development of generalized method of moment/observation (GMM) equations, (4) introduction of a conceptual and computational parameter estimation scheme, (5) introduction of a conceptual and computational state estimation scheme, and (6) derivation of -best sub-optimal state and parameter estimates. The first component is satisfied since we have a continuous stochastic S EIRS epidemic model governing the transmission of the Covid-19 virus. In order to construct equivalent time series model to the stochastic model, we need to be able to specify which state and parameters to estimate. The susceptible and exposed states are unknown, and the models governing the dynamics of the known infected and recovered population depend on the exposed population, recovery rate ν(t), and the temporary immune rate γ(t). We will estimate the states E(t) and S (t) and parameters β(t), r I , ν(t), and γ(t) in two stages. In the first stage, we apply the LLGMM scheme to the stochastic model governing the recovered population R(t) to estimate ν(t) and γ(t). These estimated parameters are now used in the model governing I 1 (t) and I 2 (t) to estimate the state E(t). The LLGMM scheme is now applied to the model governing E(t) to estimate the state S (t), asymptomatic recovery rate r I , and the transmission rate β(t). In the second stage, we use the estimated states E(t) and S (t), together with the known states I 1 (t), I 2 (t) and R(t) to update the parameters β(t), ν(t), and γ(t), and later use these estimates to simulate the states S (t), E(t), I 1 (t), I 2 (t), and R(t), and the effective and basic reproduction numbers R e and R 0 , respectively. The -best sub-optimal state and parameter estimates are now recorded.

We explain the state and parameter estimation scheme in two stages in the following subsections. In Section 3.1.1, we estimate ν(t), γ(t), r I , σ j (t), j = 1, 2, and β(t), together with the state estimates E(t) and S (t) satisfying (2.5). These estimates are updated in stage 2 of the estimation process in subsection 3.1.2. The -best sub-optimal estimates are derived in Section 3.2.

Let U(t) = S (t) + E(t). We can extract the data for U(t) using the fact that S + E = 1 − I 1 − I 2 − R. The model governing αE is obtained from the model governing S and E in (2.5) and substituted into the model governing I 2 (t) as follows:

J o u r n a l P r e -p r o o f

In order to estimate the states E(t) and S (t), we first need to estimate the parameters ν(t) and γ(t). To do this, we setup two time series model corresponding to the symptomatic infectious and recovered class as follows:

We first explain the discretization scheme as discussed in Otunuga (2017) [34] and Otunuga (2019) [35] . Let x = (S , E, I 1 , I 2 , R) be continuous time stochastic process defined on the interval [t 0 − τ, T ], where τ is a continuous delay constant (with corresponding discrete delay constant r). For t ∈ [t 0 − τ, T ], let F t be an increasing sub-sigma algebra of a complete probability space (Ω, F , P) for which

and Z is the set of integers. Define m k as the local admissible sample data observation size at time t k . For r ≥ 1,

We estimate the parameters ν(t) and γ(t) at time t j using known data (I 2 (t)) t∈P j and (R(t)) t∈P j by first integrating

It is clear from the integrals above that the estimates ν(t * j ) and γ(t * * j ) are calculated using m j data set at and to the left of time t j . Since these estimates are calculated using m j observation size at and to the left of t j , we write ν(t * j ) ≡ν t j ,m j , 6 J o u r n a l P r e -p r o o f

The third component of the LLGMM scheme is satisfied by discretizing the above integral equations and applying condditional expectation to obtain

Let ∆W l j,m j be a Wiener process with mean 0 and variance ∆t, where j ∈ K(1, N) for sample size N, l ∈ K(1, L) for L simulations, and m j ∈ K(2, r) is the observation size. LetÊ l t j ,m j be the l-th simulated exposed population estimate at time t j using m j observation size, l ∈ K(1, L). Let I 1 (t j ) = I 1 j , I 2 (t j ) = I 2 j , and R(t j ) = R j be the known asymptomatic infected, symptomatic infected, and recovered population at time t j , respectively, and setÎ l 2 t j ,m j = I 2 j andR l t j ,m j = R j . We extractÊ l t j ,m j from the discretized model governing the infected population in (2.5) using Monte-Carlo method and Euler scheme as follows:

J o u r n a l P r e -p r o o f as the estimated value of E(t) at time t j using m j observation size. From this, the simulated valueŜ j,m j of the susceptible population S (t) at time t j using m j observation size is calculated aŝ

where a and b are constants. The estimatesm j ,â,b, andr I of m j , a, b, and r I that minimize the square Ξ 1 j,m j are calculated and used to obtain the stage 1 estimate for the exposed class E(t) asÊ j,m j for each j ∈ K(1, N). The stage 1 estimateŜ j,m j for the susceptible class S (t) is calculated using (3.6) aŝ

Using the fact that there exists constantst j ,t j ∈ (t j−m j +1 , t j ) such that

we estimate the remaining parameters β(t) and σ 1 (t) by integrating the equation governing

(3.7) Following the same argument above, by discretizing and taking the conditional expectation of integrals in (3.7), the estimates β(t j ) ≡ β j,m j andσ 1 (t j , m j ) of β(t) and σ 1 (t), respectively, at time t j are obtained aŝ

In stage 2, we updated the exposed and susceptible state estimatesÊ j,m j andŜ j,m j , and parameter estimatesν j,m j andγ j,m j of ν(t) and γ(t), respectively. Similar to the outline above, let ν j,m j and γ j,m j be the updated estimates for the parameters ν(t) and γ(t), respectively, at time t j using m j data sets at and to the left of t j . The updated infectious rate ν j,m j and temporary immune rate γ j,m j at time t j are obtained as In order to update the state values at time t j , we discretize the Itô differential equations (2.5) using the implicit Euler scheme [41, 3] as described in [31] . For the stochastic model

where y = (S , E, I 1 , I 2 , R), f and g represent the drift and diffusion coefficient of system (2.5) with time-dependent parameters θ, the implicit Euler scheme gives the discretize l-th simulated solution y l j+1 ≡ y l j,m j satisfying 3.2. Derivation of -best sub-optimal state and parameter estimates We estimated, among the values {y l j ≡ y l j,m j } r m j =2 at time t j , the value closest to the known real value. Specifically, the correct delay constant m j must be determined. Let S l j,m j , E l j,m j , I l 1 j,m j , I l 2 j,m j and R l j,m j be the simulated susceptible, exposed, asymptomatic, symptomatic infectious and recovered estimate for the l-th simulation at time t j using m j observations at and to the left of t j . We take the average

as the simulated value of S (t), E(t), I 1 (t), I 2 (t), and R(t) at time t j using m j observations at and to the left of t j . Define

as the quadratic mean square error between the known data {Ŝ j,m j ,Ê j,m j , I 1 t j , I 2 t j , R t j } and the averaged realizations {S j,m j , E j,m j , I 1 j,m j , I 2 j,m j , R j,m j } r m j =2 . For any arbitrary small positive number and for each time t j , we define the -suboptimal admissible set of m j at t j as M j = {m j : Ξ j,m j < }.

(3.12)

If m j ∈ M j gives the minimum value for Ξ j,m j , then we record m j as m * j . If condition (3.12) is not met at time t j , then the value of m j where the minimum min m j Ξ j,m j is attained is recorded as m * j . The -best sub-optimal parameter and state estimates at time t j are now recorded as θ j,m * j = {β j,m * j , ν j,m * j , γ j,m * j , σ 1 (t j , m * j ), σ 2 (t j , m * j )} and {S j,m * j , E j,m * j , I 1 j,m * j , I 2 j,m * j , R j,m * j }, respectively.

of Columbia from the previous day. The recovered COVID-19 data cases were collected from the COVID Tracking Project 8 for the COVID-19 periods 04/01/2020 through 02/27/2021 and compared with the CSSE daily data.

The CDC COVID-19 data is given daily, so that ∆t = 1 day. According to CDC, the incubation period for COVID-19 is thought to extend to 14 days, with a median time of 4-5 days of exposure to symptoms onset 9 . McAloon et al.

(2020) showed in their work that the time from exposure to symptom onset is 6 days. Also, in their analysis based on confirmed cases outside Wuhan, Lauer et al. and Linton et al. [16, 18] estimated the median incubation period to be 5.0 days with a range of 2 to 14 days, similar to 5.2 days incubation period with symptom onset between 3 to 6 days reported by Li et al. [19] . For these reasons, measuring time in days, we assume α should be selected in the range [1/14, 1/2] per day and used a default value of 1/6 day −1 . The measure of the infectiousness of asymptomatic cases to symptomatic cases remains highly uncertain. According to the parameter values for the five COVID-19 Pandemic Planning Scenarios produced by CDC 10 , the infectiousness of asymptomatic individuals relative to symptomatic is estimated to be η = 0.75. From the CIA World Factbook 11 , the current population of the United States as at July 2020 is 332, 639, 102. So, we set N = 332, 639, 102. Also, The annual U.S. birth rates for the year 2020 is 12.4 births per 1000 population, while the death rate is 8.3 death per 1000 population and life expectancy is 80.3 years 12 . Therefore, we set µ to be in the range 

The COVID-19 infected 6 and recovered 8 data plot are shown in Figure 2 (a) and (b), respectively. Using the S EIRS model, and setting the latency rate α = 1/6, the exposed population {E(t j )} N j=r+1 is estimated in stage 1 as {Ê j,m } N j=r+1 using the LLGMM scheme with delay constants r = 90 days (with 2 ≤ m j ≤ 90) and r = 150 days (with 2 ≤ m j ≤ 150). The estimates at time t j are calculated using m j past data points at and to the left of t j . These values are estimated in stage 1 of the estimation stage in Subsection 3.1.1 and values plotted in red color in Figure 4 . The Susceptible population {S (t j )} N j=r+1 is estimated in stage 1 as {Ŝ j,m } N j=r+1 using delay constants r = 90 days (with 2 ≤ m j ≤ 90) and r = 150 days (with 2 ≤ m j ≤ 150) with the fact that S + E + I 1 + I 2 + R = N. These values are plotted in red color in Figure 3 . It can be seen from the estimated exposed and susceptible population that when the trend of the infected cases increases (decreases) in the months when the number of those who are exposed also increases(decreases) and the number of those susceptible to COVID-19 decreases (increases). . These time varying parameters are later used in stage 2 in Subsection 3.1.2 to simulate the susceptible, exposed, infected and recovered population. We note here that there are m j estimates for each values S j,m j , E j,m j , I 1 j,m j , I 2 j,m j , and R j,m j . The best estimates, otherwise known as the -best sub-optimal parameter and state estimates, The simulated susceptible {S j,m * j } N j=r+1 and exposed {E j,m * j } N j=r+1 population are shown (in blue) in Figures 3 and 4 , respectively. The results in Figure 3 (a) and (b) are derived using maximum delay constants r = 90 and r = 150 days, respectively, corresponding to 3 and 5 months past data. We noticed a decline in the number of susceptible individuals 11 J o u r n a l P r e -p r o o f in the time periods 10/01/2020-12/24/2020. These periods fall around the festive Thanksgiving and Christmas in the United States when people travel around the country. We also notice an increasing trend in the number of individuals susceptible to the disease from december, 2020 to February, 2021. These period coincides with the period when the daily count of total Covid-19 vaccine doses administered is also increasing. Further research is being done to analyze the correlation between these two occurences and to discuss factor(s) contributing to the incline and decline in the susceptible population. The blue plot in Figure 4 is the trajectory of the simulated exposed population {E j,m * j } N j=r+1 . The side by side comparison of the trajectories of the estimated {Ê j,m j } N j=r+1 and simulated {E j,m * j } N j=r+1 exposed population in Figure 4 shows that the LLGMM algorithm fits well and the algorithm seems to prefer using many past data points as seen in Figure 16 , with better result in Figure 4 (b) where the maximum delay constant is r = 150 days. The results in Figure  4 

J o u r n a l P r e -p r o o f infected infectious population using delay constant r = 90. Figure 5(b) shows the comparison of the real 6 (red) and simulated {I j,m * j } N j=r+1 (blue) infected infectious population using delay constant r = 150. The number of infected and exposed cases rise in the month of October, November and December. As explained above, these periods fall around the festive Thanksgiving and Christmas in the United States when people travel around the country. We noticed a decline in the number of exposed and infected individuals starting around late December 2020 to late February 2021 when the daily count of total Covid-19 vaccine doses administered is also increasing. Analysis is currently being done to investigate if there is any correlation between the daily counts of exposed, infected, recovered individuals and the daily count of total Covid-19 vaccine doses administered. Figures 7 and 9 , respectively,) starting from late december, 2020. This decrease is probably due to current interventions like the use of these vaccines. The average of the transmission rate using r = 90 days delay constant is 0.1073 per day. In their work, Lingzhi et al. [21] used the DELPHI v2p8 (Differential Equations Leads to Predictions of Hospitalizations and Infections) model to predict β(t) and claim it is of the form 2 π arctan − (t−ā) b + 1, for some constantsā andb. We verify the validity of their claim by fitting the equation

to the data {β j,m * j } N j=r+1 . The parameters a, b, and c are estimated in the Table 2 and the trend of {β j,m * j } N j=r+1 compared with the DELPHI model in Figure 8( Also in their work, Eikenberry et al. [6] and Tang et al. [42] claim that β(t) follows a decreasing exponential model of the formβ

where β 0 is the initial contact rate at the initial time t 0 (July 1, 2020), β 1 is the minimum contact rate, and r is the rate at which contact decreases. We check to see if our result agrees with theirs by fitting equation (4.2) to the data {β j,m * j } N j=r+1 . The parameters r, β i , i = 0, 1 are estimated in Table 3 and the trend of {β j,m * j } N j=r+1 compared with the exponential model in Figure 8( Our result shows the exponential model fits the transmission rate {β j,m * j } N j=r+1 better than the DELPHI v2p8 model, with a root mean square of 0.01635. However, these two models fail to capture the trajectory of the transmission rate for recent months. It also fails to capture spikes in the transmission rate. For these reasons, by studying the trajectory of the transmission rate from the month of July 2020 to February 2021, we propose a mixed Gaussian model of the formβ

where a j , b j , c j , M, j = 1, 2, · · · , M, are constants estimated in Table 4 The trend of the transmission rate {β j,m * j } N j=r+1 is compared with that of the proposed model (4.3) and the graph plotted in Figure 9 . The proposed model (4.3) gives a better root mean square error of 0.0135 when compared with that of the DELPHI (4.1) and exponential (4.2) models.

J o u r n a l P r e -p r o o f J o u r n a l P r e -p r o o f days and r = 150 days, respectively. We calculate the average of the symptomatic recovery rate to be 0.0907 using r = 90 days. We notice here that this average is close to the estimated asymptomatic recovery rate r I = 1/10.5 estimated in Table 1 . We fit the curveν

whereā j ,b j ,c j , j = 1, 2, · · · , 3 are constants estimated in Table 5 . Our fit suggests that after a long decline, the symptomatic recovery rate for Covid-19 started increasing around the month of November 23, 2020 to the end of our analysis (February 25, 2021) . The increase speeds up (graph concaves up) until January 18, 2021 and starts slowing down (graph concaves down) after that date. Studies on the cause of the increase is ongoing. shows the trajectory of the temporary immune rate {γ j,m * j } N j=r+1 using delay constants r = 90 days and r = 150 days, respectively. The trend shows the trajectory of the temporary immune rate behaves like that of the function t n e −bt . We calculate the average temporary immune rate to be 0.2139 using r = 90 days delay constant.

We fit the curveγ 1 (t) = a 1 e −b 1 t t n + c 1 (4.5) to the data {γ j,m * j } N j=r+2 in Figure 13 . The parameters a 1 , b 1 , c 1 , and n are estimated in Table 6 . Figure 16 shows the sample observation size m * j used at each time t j in the LLGMM procedure, as explained in Subsection 3.2 and determined by the computation itself. Figure 16 (a) and (b) shows the distribution of the time delay using maximum time delay r = 90 and r = 150, respectively. Notice that the algorithm seems to prefer using many past data points as evidenced in Figures 3, 4 , 5, and 6.

In order to understand the outbreak dynamics of COVID-19, taking into consideration vital dynamics, we study a powerful quantitative concept that can be used to characterize the contagiousness and transmissibility of the infectious disease [17] . The basic reproduction number (denoted R 0 ), is the expected number of secondary cases produced by a typical infectious individual in a completely susceptible population. Unfortunately, the number lacks the ability to explain the effects of public health interventions [4] . Realistically, population will rarely be totally susceptible to an infection in the real world. Some contacts will be immune, for example, due to prior infection which has conferred life-long immunity, or as a result of previous immunization. Therefore, not all contacts will become infected and the average number of secondary cases per infectious case will be lower than the basic reproduction number R 0 . We quantify these effects, together with the public health interventions for every point in time, using what we call the effective reproduction number (denoted R e (t)). The effective reproduction number R e (t) is the expected number of secondary cases produced by a typical infectious individual in a population where not everyone is susceptible [9] . This number changes dynamically in response to public health interventions. The estimated contact/transmission rate β(t) and temporary recovery rate ν(t) plotted in Figures 7 and 10 , respectively, are used to estimate the reproduction numbers for the COVID-19 as follows:

Using the next generation matrix approach [5] , we first obtain the basic reproduction number R 0 at the onset of the pandemic (that is, at t 0 ). This result is now generalized to calculate the effective reproduction number R e (t). Denote β(t 0 ) = β 0 and ν(t 0 ) = ν 0 as the contact rates and symptomatic recovery rates at the onset of the pandemic, respectively. Using the notations in van den Driessche et al. [5] , the non-negative matrix F representing matrix of new infection terms and the non-singular matrix V representing transfer of individuals in and out of a particular compartments, are obtained as

J o u r n a l P r e -p r o o f respectively. The basic reproduction number R 0 is obtained by calculating the spectral radius of the next generation matrix FV −1 and obtained as

Here, α α+µ is the fraction of individuals progressing from the exposed class to the infectious class (probability of surviving the exposed period and progressing to infectious class), and 1 r I +µ and 1 v(t 0 )+µ are the mean time spent being asymptomatic and symptomatic infectious, respectively, at the start of the epidemic. From this, in the presence of public health interventions (such as mask wearing, 6-feet distancing, vaccinations, et.c.), we obtain the effective reproduction number R e (t) as

where β(t) ≡ β j,m * j , ν(t) ≡ ν j,m * j are estimated and fitted in Tables 5, 4 , and Figures 7, 10 . Information about the magnitude of the reproduction number at each time t helps to understand the outbreak dynamics of an infectious disease [17] . This result is used to analyze the outbreak dynamics of Covid-19 cases in the United States.

(a) (b) Figure 17 : Effective Reproduction number R e (t) using latency rate α = 1/6 Figure 17 shows the number of new infections caused by one Covid-19 infectious individual in a population that is not completely susceptible due to public health interventions. This was derived from (4.7), where β(t) ≡ β j,m * j , ν(t) ≡ ν j,m * j are the -best estimates for the transmission rate β j,m * j and temporary recovery rates ν j,m * j . These rates are plotted and fitted in Figures 7, 10 and Tables 5, 4 , respectively. The estimated average effective reproduction number in the month of August 2020 to February 2021 are given in Table 7 .

Average We see from the graph estimates that the effective basic reproduction number falls below 1 from January 10, 2021 to the end of our simulation period (February 25, 2021). Studies concerning the possible decline in R e (t) in these months is ongoing, but we suspect the introduction of vaccines into the system might be one of the major contributor to the decline. We see from the plot of the effective reproduction number that the regions where there are spikes correspond to regions in the plot of the transmission and recovery rates β j,m * j and ν j,m * j where there is spikes. As it is well known [32, 30] , if R 0 < 1, then the number of infection cases converges to zero on the long run (that is, the virus will stop spreading on the long run). Likewise, R 0 > 1 means epidemic is growing on the long run. The result above shows that on the average, epidemic was growing in the month of November and December 2020, and started to decline in the month of January and February, 2021. This is consistent with the analysis of the transmission and symptomatic recovery rate of the disease. As seen in Figure 17 (b), we fit the curvē

to the data {R e (t j )} N j=r+2 in Figure 17 (a). The parameters a j , b j , c j , d j , j = 1, 2, 3, 4, are estimated in Table 8 . 

In this study, the outbreak dynamics of Covid-19 is discussed and analyzed using a Stochastic SEIRS dynamic epidemic model with case study of COVID-19. In the case study, the local lagged adapted generalized method of moments (LLGMM) parameter identification scheme was used to extract the exposed and susceptible population and to identify the time-dependent transmission, recovery, temporary immunity rate, infection noise intensities, and the reproduction numbers (basic and effective reproduction numbers) from the COVID-19 data from March 2020 to February 2021 using time delays r = 90 and r = 150 days (equivalent to three and five months past data, respectively). Valuable information on the susceptible and exposed population, together with the epidemiological parameters and the reproduction numbers of COVID-19 are obtained with the help of the LLGMM scheme.

From the graph of the infection cases in Figure 2 , we see that the trajectory of the infected population is similar to that of the estimated exposed population. Also, the trend of the estimated susceptible population shows that as the number of infection cases increase (decrease), the estimated number of susceptible population decreases (increases). Using the estimated exposed and susceptible population, we estimated the time varying parameters in the S EIRS epidemic model. We see from the parameter estimates that there are spikes in the transmission rate β(t) of Covid-19 in the month of November and December 2020. The number of infection and exposure to Covid-19 also increase in the 23 J o u r n a l P r e -p r o o f same months. These months correspond to festive periods in the United States when people travel around the country. Also, these number reduces, starting from the month of December 24, to the end of our analysis period. These period corresponds to the period when the daily count of total Covid-19 vaccine doses administered increases. A model was derived to fit the time-dependent transmission rate (with a root mean square error (RMSE) of 0.0135). The model is compared with the work of Lingzhi Li et al. [21] , Eikenberry [6] and Tang et al. [42] and shown to fit the transmission rate better. We showed that our result is consistent with their result.

The recovery rate ν(t) of Covid-19 was estimated for the cases where α = 1/6, with µ = 1 80.3×365 and time delays r = 90 and r = 150. A model was derived to fit the time-dependent recovery rate (with a root mean square error of 0.01505). Our studies show that the recovery rate increases around November 23, 2020 to the end of our analysis period (February 25, 2021) . Studies of the cause of increase is ongoing.

The temporary immune rate γ(t) was also estimated using time delays r = 90 and r = 150. A model was derived to fit the time-dependent temporary immune rate.

Finally, we estimated the basic and effective reproduction numbers for the Covid-19 virus. These numbers are calculated using the Next Generation Matrix approach. Our studies show that the effective reproduction number fluctuates around the number 1, and rises above 1 on the average in the month of November and December, 2020. That is, epidemic was growing in the months of November and December, 2020 during the Thanksgiving and Christmas period. The number of infection reduces on the average in the month of January 2021 and mostly in February, 2021 probably due to the introduction of the Pfizer and Moderna Covid-19 vaccines in the United States. The first dose of the Pfizer vaccine was administered on December 14, 2020. We discovered that on the average, using latency rate α = 1/6, epidemic was more pronounced in the months of November, December 2020, and January 2021 than in other months. The growth reduces in the month of January and February. We see a decline in the transmission rate of the disease starting late December, 2020 to February, 2021. A possible cause of the decline might be attributed to the introduction of Pfizer-BioNTech and Moderna Covid-19 vaccine on December 11 and 18, 2020, respectively. We are currently studying the cause of the decline by checking if there is any correlation between the estimated transmission rate and the number of vaccination in the United States. A Gaussian model was used to fit the reproduction number with a root mean square of 0.3613.

Further studies on the Covid-19 outbreak is ongoing and results of our findings will be published as it becomes available.

The data used in the analysis can be found on the CDC 6 website.

The author declares that there is no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.

The author carried out the research work and drafted the manuscript.

J o u r n a l P r e -p r o o f

Adaptive dynamic modeling of HIV/AIDS epidemic using extended Kalman filter

Global identificaiton of the parameters of a nonlinear systems with specified input: A comparison of methods

Maple for Stochastic Differential Equations

Complexity of the basic reproduction number (R 0 )

Reproduction numbers and sub-threshold endemic equilibria for compartmental models of disease transmission

To mask or not to mask: Modeling the potential for face mask use by the general public to curtail the COVID-19 pandemic

Large sample properties of generalized method of moments estimators

Global projections of potential lives saved from COVID-19 through universal mask use. Preprint at medRxiv

IHME COVID-19 Forecasting Team, Modeling COVID-19 scenarios for the United States

Seeing the Wood for the Trees: A critical Evaluation Method to Estimate the Parameters of Stochastic Differential Equations

Estimation of the Parameters of Stochastic Differential Equations, PhD Dissertation

Uhlmann Unscented filtering and nonlinear estimation

A new approach to linear filtering and prediction problems

Numerical solution of stochastic differential equations

An introduction to differential equations: Stochastic modeling, methods and analysis

The Incubation Period of Coronavirus Disease 2019 (COVID-19) From Publicly Reported Confirmed Cases: Estimation and Application

The reproduction number of COVID-19 and its correlation with public health interventions

Incubation period and other epidemiological characteristics of 2019 novel coronavirus infections with right truncation: a statistical analysis of publicly available case data

Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia

On global identifiability for arbitrary model parameterizations

Bertsimas Overview of DELPHI Model V2.8-Covid Analytics

Assessing the role of quarantine and isolation as control strategies for COVID-19 outbreak: a case study

The incubation period of COVID-19: A rapid systematic review and meta-analysis of observational research

Stochastic fluctuations of the transmission rate in the susceptible-infected-susceptible epidemic model

The annual impact of seasonal influenza in the US: Measure disease burden and costs

Mathematical modeling of COVID-19 epidemic with effect of awareness programs

Mathematical modeling of COVID-19 transmission dynamics with a case study of Wuhan

Analysis of a mathematical model for COVID-19 population dynamics in Lagos

Local lagged adapted generalized method of moments Dynamic Process

Qualitative analysis of a stochastic SEITR epidemic model with multiple stages of infection and treatment

Otunuga Parameter identification for a stochastic SEIRS epidemic model: case study influenza

Global stability for a 2n + 1 dimensional HIV/AIDS epidemic model with treatments

Time varying parameter estimation scheme for a linear stochastic differential equation

Local lagged adapted generalized method of moments and applications

Local lagged adapted generalized method of moments: an innovative estimation and forecasting approach and its applications

Positivity and boundedness of solutions for a stochastic seasonal epidemiological model for respiratory syncytial virus (RSV)

A new mathematical model of COVID-19 using real data from Pakistan

System identifiability based on the power series expansion of the solution

Extracting the time-dependent transmission rate from infection data via solution of an inverse ODE problem

A modelling framework to assess the likely effectiveness of facemasks in combination with 'lock-down' in managing the COVID-19 pandemic

Numerical regularization for SDEs: Construction of nonnegative solutions

An updated estimation of the risk of transmission of the novelcoronavirus

Similarity transformation approach to identifiability analysis of nonlinear compartment models

An introduction to infectious disease modelling

Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China: a modelling study

Structural basis of preexisting immunity to the 2009 H1N1 pandemic influenza virus

On a nonautonomous SEIRS model in epidemiology